Novo Nordisk and HFA Collaboration: Hopeful Future for Hemophilia B
Hemophilia Federation of America (HFA) shared a reminder post on X:
”Time is running out to register!
Join us tomorrow, July 29 ,at 7pm ET for Living with Hemophilia B: From Challenges to Hopeful Futures, an interactive virtual event presented in partnership with Novo Nordisk.”
Register now.
In collaboration with Novo Nordisk, the Hemophilia Federation of America (HFA) will host a virtual presentation on July 29 at 7 p.m. EST, led by Dr. Robert Sidonio.
This interactive session will explore the everyday challenges faced by individuals living with hemophilia B and provide a platform for open dialogue around personal experiences, treatment roadblocks, and future hopes for disease management.
With a focus on community engagement and patient-centered care, the event aims to foster shared understanding and highlight evolving needs in hemophilia B care.
Do not miss any conference or webinar on hemophilia management, read Hemostasis Today.
-
Jul 8, 2026, 21:30Matthew Gouveia: How VNS-REHAB Is Transforming the Future of Stroke Rehabilitation
-
Jul 8, 2026, 21:22What Hundreds of Stroke Stories Have Taught Diana Kerr About Recovery and Resilience – Stroke Foundation
-
Jul 8, 2026, 19:50Heghine Khachatryan: Why the EHC Fully Supports the Lancet Commission on Women’s Hematological Health
-
Jul 8, 2026, 19:40Autoregulation Failure in SVD and Cognitive Impairment – International Journal of Stroke
-
Jul 8, 2026, 19:30Ahmed Mostafa: Why Antibodies Cause Organ Rejection
-
Jul 8, 2026, 19:28Erika Bocanegra: Witnessing 25 Years of Progress in Bleeding Disorders Care
-
Jul 8, 2026, 19:27Ahmadou Ouedraogo: Do You Know Your Blood Type?
-
Jul 8, 2026, 19:26Javed Anees: An Evidence-Based Clinical Guide to ESA Therapy
-
Jul 8, 2026, 19:25Paul Breillat: Nature Reviews Rheumatology Highlights Our VEXAS Syndrome Research